Stay updated on Long-Term Follow-Up of Dupilumab Safety in Asthma Clinical Trial
Sign up to get notified when there's something new on the Long-Term Follow-Up of Dupilumab Safety in Asthma Clinical Trial page.

Latest updates to the Long-Term Follow-Up of Dupilumab Safety in Asthma Clinical Trial page
- Check2 days agoChange DetectedRevision: v3.5.0 added and Revision: v3.4.3 removed.SummaryDifference0.0%

- Check9 days agoChange DetectedWebsite revision updated from v3.4.2 to v3.4.3.SummaryDifference0.0%

- Check16 days agoNo Change Detected
- Check23 days agoNo Change Detected
- Check37 days agoChange DetectedAdded Revision: v3.4.2 and removed the prior government-funding status notice, updating revision history and site status.SummaryDifference0.2%

- Check45 days agoChange DetectedA new site-wide notice about government funding lapse and NIH Clinical Center status has been added, and the page revision now shows v3.4.1 replacing v3.4.0. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check52 days agoChange DetectedThe page adds a Show glossary option and updates metadata fields (Last Update Submitted that Met QC Criteria, No FEAR Act Data, Revision: v3.4.0) along with capitalization changes.SummaryDifference0.1%

- Check66 days agoChange DetectedThe page shows a revision update from v3.3.3 to v3.3.4. The visible study details appear unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

Stay in the know with updates to Long-Term Follow-Up of Dupilumab Safety in Asthma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Long-Term Follow-Up of Dupilumab Safety in Asthma Clinical Trial page.